|
Latest Posts By sheerluck
- Supreme
|
|
| 02-Jul-2015 23:10 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
The 29 April announcement said " Patent Claim and the State Law Claims" .   Wouldn' t QTV lose it if they lose the case?
|
||||
| Good Post Bad Post | |||||
| 02-Jul-2015 20:55 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
there' s a good qn. shareholder should email qtv mgmt. also if they lose the appeal, it will be a double whammy.   Lose usd20mil and patent for chocolate.
|
||||
| Good Post Bad Post | |||||
| 02-Jul-2015 20:30 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
Now this can be really bad for QTV as it might also affect the USD12mill funding raising exercise. ********************************************************************************************************************** 3.2. Conditions Precedent The obligation of the Purchasers to subscribe and pay for the Bonds is subject to the following conditions precedent: (a) at the Closing Date (i) all the representations and warranties of the Company set forth in the Agreement shall be accurate and correct and not misleading in all respects at, and as if made on, the Closing Date (ii) the Company shall have performed all of its undertakings or obligations under the Agreement required to be performed by it on or before the Closing Date (b) the results of the due diligence exercise being to the satisfaction of the Purchasers (at their sole discretion) (c) the Purchasers being reasonably satisfied that, on the Closing Date, there is no material adverse change occurring in the prospects, results of operations or financial conditions of the Company, or the Group taken as a whole and (d) the approval of the Singapore Exchange Securities Trading Limited (" SGX-ST" ) for the listing and quotation of the Conversion Shares (as defined below) on the SGX-ST and all other consents, approvals and authorizations having been obtained by the Company and the same continuing to be in full force and effect. ********************************************************************************************************************** The investor may pull out or demand an even more protective clause and hence more damages to existing shareholders.   As usual no impact to the coy so long as they can get the $$$ to keep operation going.   New investors must be saying heng ah.   |
||||
| Good Post Bad Post | |||||
| 02-Jul-2015 19:38 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
This is indeed a bad news for QTV.   Does the CEO need to bear some of it since it is against him as well?   Well if he starts selling his shares......
|
||||
| Good Post Bad Post | |||||
| 01-Jul-2015 11:28 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
A reflection of how much risk the new investors see in this investment and also a reflection of how much mgmt is willing to sacrifice existing shareholder' s interest.  
|
||||
| Good Post Bad Post | |||||
| 01-Jul-2015 10:49 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
Should be " 8.5% premium to QTV weight average price"
|
||||
| Good Post Bad Post | |||||
| 01-Jul-2015 10:46 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
Let see what this means for the company, the new investors, and the existing shareholders. Cash call was expected since QTV is running out of cash.   As mentioned their cash burnt rate is very high.   They burnt all the IPO proceed of USD 40mil within a years.   So this cash injection is definitely required to keep the company going.   Whether there are any good news, and if any, when? We don' t know for sure.   There is nothing good or bad about it for the company.   It is just a necessary action. For the new investors the way the CB are structured effectively eliminate their risks.     While the conversion price is at 8.5% discount to QTV weight average price, an interest of 8% p.a means in one year time they reduced their risk to zero except in the case QTV default on their bonds (likely?).   After that, it is all profit for they.   If QTV share price boom, they can convert to cash in.   They can converted into about 11% of the company existing shares.   That' s quite a huge amount of shares for the market to absorb or for the retailers to babysit!   If QTV share price tank, they dont convert and can ask for redeemption.   Either way, the new investors never lose. For existing shareholders,  it will be prudent to think about what this means. On the way they did the fund raising. Why did they not loan from a bank?   With EDB as backer, I am pretty sure, they can get one with a much lower interest rate.   It will be better than issue CB.   Of coure with a bank loan, they have to repay the principle  or refinance  on maturity.   So this suggested to me that they are not so confident in their cash generating ability to repay the principle and they do not want to have loan in their already weak BS. Why did they not simply do a share placement?   Well, if QTV price tank, the new investors will lose money. CB will be the best for the new investors because they are so well protected.   The only risk is QTV default on their bond.   Other than that, they sure win.   But with the CB, the compnay have more liabilities and if QTV really tank and CB holder ask for redemption, who is going to pay the price?   Not the company.   There is this one big ATM- the market and who has been putting money into this ATM? So what happen to these new risks in addition to the existing risks?   Who are carrying them now?   Not QTV.   It got the cash it need to function now.   Not the new investors.   They have protections against any risks after a year or so. I hope to see some useful discussion on this.   |
||||
| Good Post Bad Post | |||||
| 24-Jun-2015 14:30 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
Haha!   My vision has served my well till now.
|
||||
| Good Post Bad Post | |||||
| 24-Jun-2015 14:28 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
I don' t deny that about the acquisition of Lutonix.   It was a private company when it was being acquired.   CR Bard must have see something in the PAD and CAD market to pay this price tag for Lutonix. But why was QTV not being acquired when it was still a private coy and instead was push out for listing when it has already got FDA approved, CE Mark and CFDA approved products? Anyway, for QTV price to appreciate or to be appreciated, one of these must happen: - big bio coy express interest to acquire QTV or - good sale performance by QTV. Now, we don' t know when the first will happen if it does but we do know that every 3 month we get some sale figures from QTV.   Unless the market hear some rumour about acquisition, it will probably rely on the sale figures.
|
||||
| Good Post Bad Post | |||||
| 24-Jun-2015 14:10 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
Indeed but having vision but a poor one can also lead to disastrous outcomes.  
|
||||
| Good Post Bad Post | |||||
| 24-Jun-2015 13:51 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
Hmm.. I am wondering if QTV is really cheap now. By market cap, it is one of the lowest of about USD92mil but by EV/rev, it is about twice compared to other US listed Vascular coy.   While it is about 20% below industrial averge of 8, those US listed Vascular coy are about half. Hmm.. I am wondering if QTV is really good now. One year on from signing new sale model with Cordis, sale is so-so.   Not growing like what those analysts are selling to retailers.   Chocolate Touch apporval coming 2HFY15, so the coming quarter and next quarter sale performance will rely on their existing Chocolate and Glider. Well we should see....
|
||||
| Good Post Bad Post | |||||
| 24-Jun-2015 13:37 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
If you have bought care to share the reasons? If so, you might want to re-examine those reasons. Also I don' t short, I just share my views.   If you got some, I would like to hear them as well.  
|
||||
| Good Post Bad Post | |||||
| 24-Jun-2015 10:02 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
Wah.   You people really anyhow hantan. This article is saying " cardiac prosthetic devices" for eg stents.   QT Vascular products are catheter balloons and they are promoting the reduced use of stents especially with their DCB. Now the article mentioned these: Market Driver: Rise in birth prevalence of congenital heart disease worldwide Market Challenge: Risk of complications and re-interventions Market Trend: Increase in use of low-profile stents grafts for aneurysm repair The point on market driver is to QTV advantages but same to all other competitors. The point on market challenge is neutral to QTV but can be viewed negative wrt the next point. But the point on market trend is against QTV.   QTV is advocating reduced use in stent but the trend is against them. You' ll say DCB is a market wanted product but agree with articale that said otherwise. You people anyhow hantan.   jialat siah.  
|
||||
| Good Post Bad Post | |||||
| 21-Jun-2015 15:18 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
I admire your conviction.
Anyway, if you can post news on their product approval, it will be useful. More useful if it is factual.
|
||||
| Good Post Bad Post | |||||
| 21-Jun-2015 10:57 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
Finally some not so useless info.   QTV expect CE mark for Chocolate Touch in second half of FY15.   Maybe next month or next six months.   We can only start seeing if this Chocolate touch sells probably next year.   In the meantime, the market might continue to punish QTV for their lack of performance.   Also QTV sale in EU is very low.  
|
||||
| Good Post Bad Post | |||||
| 21-Jun-2015 10:45 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
Would be better if more forummers can contributes more info.  
|
||||
| Good Post Bad Post | |||||
| 20-Jun-2015 17:53 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
Really hor...anyway for the benefit of the others.... since Trivascular was brought up then let see some figures: TriV IPO-ed at USD12 per share with EV/sale was about 13.   QTV IPO-ed at SGD0.28 with  EV/sale was about 23.   So who got a better deal?   SG investors really ganna chop veg head and some analysts really blow it up like a real good deal.   Now people suffers. TriV now traded at USD6.87 per share with EV/sale was about 3.9.   QTV TriV now traded at SGD 0.18 per share with EV/sale was about 6.4.   Based on industrial average of EV/sale=8 (from CIMB analyst report), TriV should be priced at USD13.4 (ie upside is +100%).   QTV can be priced at SGD0.22 (ie upside is +25%). So did SG market really undervalued QTV in the first pace and now?   Are there further risks to QTV pricing now?   You decided.
|
||||
| Good Post Bad Post | |||||
| 20-Jun-2015 17:36 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
If you insist.........
|
||||
| Good Post Bad Post | |||||
| 20-Jun-2015 14:38 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
I looked at CIMB analyst report on QTV with a target price of $0.73 with various assumptions.   I picked up two points for those vested in QTV considerations: 1.   This TP of $0.73 is assuming QTV sale rev hit USD45mil by FY16 with PATMI USD13.5mil.   If QTV last few quarter' s performance shows that it going towards that direction, it price may move towards $0.73 before end FY16.   Unfortunately, it is not which brings me to my second point. 2.   CIMB analyst projected QTV FY15 rev to be USD28mil.   FY15 Q1 rev is USD3.3mil which is 12% of the projected rev.   Looking at the past few quarters after they had the sale model agreement with Cordis, rev were in fact pretty flat at about USD3.2 to USD3.7mil.   The company really need to show to the market that they can grow sale which they haven' t. On valuation, if they maintain current sale level, they will only achieve 1/3 of FY16 sale target.   Based on the EV/sale TP of $0.57, 1/3 of it is $0.19. Let see if Q2 sale can bring the comfort shareholders are looking for.  
|
||||
| Good Post Bad Post | |||||
| 20-Jun-2015 13:57 |
QT Vascular
/
QT Vascular Going BIG
|
||||
|
|
Trivascular outstanding shares  20.4mil.   QTV  outstanding shares 766mil.   Bro, you want to present info in this way, you will never be in charge. By comparing to Trivascular, you really shoot yourself in your own foot.   Any acquisition if any, Trivascular queue in front of QTV by current valuation.  
|
||||
| Good Post Bad Post | |||||
| First < Newer   4041-4060 of 4389 Older> Last |

